I'm taking a stab in the dark but I would imagine the biggest synergy would come from Medcann needing QBL's $5,000,000 to fit out their facility & in return we have all but one critical license & approved facility to advance our business rapidly.
It does remove the concerns surrounding the question of will we get the necessary licenses approved in time to capitalize on emerging markets or at all for that matter.
There would probably be more less obvious synergy amounting from this deal like shared industry knowledge, network contacts etc.
Looking forward to the company presentations.
Have a great weekend.
QBL Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held